Vicarious Surgical, a next-gen robotics technology company, has appointed Joseph Doherty as chairman of the company’s board of directors. Doherty has been a board member since June 2025.

Doherty was CEO of the Worcester City Campus Corporation, a not-for-profit corporation, since January 2025. He’s held a number of senior leadership positions in the healthcare and medical device industries.

He was president of Scapa Healthcare and sat on the board of Scapa Group. Doherty was also president of Olympus Surgical Technologies America. Earlier in his career, he spent 24 years at Johnson & Johnson in roles of growing responsibility, culminating as VP of Integration and Transformation.

Doherty has also served on the boards of the Massachusetts Biomedical Initiative, Immertec, and ZATA Pharmaceuticals, and as an advisor to AccuTec and Boardwalk Robotics.

“Since joining Vicarious Surgical, I’ve had the opportunity to work closely with Joe and greatly value his perspective,” said Stephen From, who became Vicarious Surgical’s CEO last month. “As Chairman of the Board, he brings a wealth of experience and thoughtful leadership that will serve the Company well. I look forward to partnering with him and the Board as we advance on our mission of transforming surgical robotics and driving value for patients and shareholders.”

The company’s novel surgical approach uses proprietary, human-like surgical robots to virtually transport surgeons inside the patient to perform minimally invasive surgery.

“I am honored to serve as Chairman at a pivotal moment for Vicarious Surgical,” said Doherty. “Our technology is designed to set a higher standard in minimally invasive surgery and has the potential to set a new standard for robotic surgery and enhance patient outcomes worldwide. I look forward to partnering with Stephen, the Board, and the team to focus our strategy, execute with discipline, and deliver better outcomes for patients and value for shareholders.”